Showing results (2131-2140 of 2,507) with videos related to

Sort By:
Pageof 251
Oncology Reports|April 24, 2014
Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinomaWei Kang, Joanna H M Tong, Anthony W H Chan, et al.
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|February 1, 1989
Bone marrow involvement in non-Hodgkin's lymphomaH S Lai, H F Tien, H C Hsieh, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|August 1, 1993
Five-year experience of human immunodeficiency virus type 1 national screening program implemented at Veterans General Hospital-TaipeiD L Cheng, Y C Liu, W T Liu, et al.
Optics Letters|June 13, 2025
Dual-excitation multispectral fluorescence lifetime imaging handheld endoscope for label-free metabolic and biochemical imaging of the oral mucosaGabriel Tortorelli, Rodrigo Cuenca, Michael J Serafino, et al.
The American Journal of Surgical Pathology|November 2, 2001
Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomasL Cheng, J Gu, J N Eble, et al.
Cell Death & Disease|March 4, 2011
C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivoQ-y Zhu, Z Wang, C Ji, et al.
NMR in Biomedicine|September 1, 2025
Automatic Identification of Potential Cellular Metabolites for Untargeted NMR MetabolomicsJiashang Chen, Angela Rao, Rajshree Ghosh Biswas, et al.
Oncogene|November 29, 2016
TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stabilityW-T Liu, K-Y Huang, M-C Lu, et al.
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|February 1, 1989
Adult non-Hodgkin's lymphoma in Taiwan area: a clinicopathologic study of 123 cases based on working formulation classificationA L Cheng, Y C Chen, I J Su, et al.
Endocrinology|November 26, 2002
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptorsS Derick, L L Cheng, M J Voirol, et al.
Pageof 251